Literature DB >> 11269705

Production, isolation and structure determination of novel fluoroindolocarbazoles from Saccharothrix aerocolonigenes ATCC 39243.

K S Lam1, D R Schroeder, J M Veitch, K L Colson, J A Matson, W C Rose, T W Doyle, S Forenza.   

Abstract

Saccharothrix aerocolonigenes ATCC 39243 produces an indolocarbazole antitumor agent rebeccamycin under submerged fermentation conditions. Adding DL-6-fluorotryptophan to culture of S. aerocolonigenes ATCC 39243 induces the formation of two novel indolocarbazoles, fluoroindolocarbazoles A and B. Feeding DL-5-fluorotryptophan to culture of S. aerocolonigenes ATCC 39243 induces the production of a novel indolocarbazole, fluoroindolocarbazole C. These fluoroindolocarbazoles have been isolated from culture broth and purified to homogeneity by vacuum liquid chromatography and column chromatography. All three fluoroindolocarbazoles are more potent than rebeccamycin against P388 leukemia by ip route in murine model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269705     DOI: 10.7164/antibiotics.54.1

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Cytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691.

Authors:  Khaled A Shaaban; Sherif I Elshahawi; Xiachang Wang; Jamie Horn; Madan K Kharel; Markos Leggas; Jon S Thorson
Journal:  J Nat Prod       Date:  2015-06-19       Impact factor: 4.050

3.  Molecular analysis of the rebeccamycin L-amino acid oxidase from Lechevalieria aerocolonigenes ATCC 39243.

Authors:  Tomoyasu Nishizawa; Courtney C Aldrich; David H Sherman
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

4.  A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer.

Authors:  Sanjay Goel; Scott Wadler; Anthony Hoffman; Fabio Volterra; Cheryl Baker; Elliot Nazario; Percy Ivy; Alyson Silverman; Sridhar Mani
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

Review 5.  Natural products for cancer chemotherapy.

Authors:  Arnold L Demain; Preeti Vaishnav
Journal:  Microb Biotechnol       Date:  2010-11-18       Impact factor: 5.813

6.  A Co-Culturing Approach Enables Discovery and Biosynthesis of a Bioactive Indole Alkaloid Metabolite.

Authors:  Fleurdeliz Maglangit; Qing Fang; Kwaku Kyeremeh; Jeremy M Sternberg; Rainer Ebel; Hai Deng
Journal:  Molecules       Date:  2020-01-08       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.